MALLIK AMEET — SEC Form 4 filings

SEC reporting owner CIK 1861441. 9 Form 4 filings on record with FilingPulse; latest filed 2026-07-02.

Transaction summary — filings shown

Covers all 9 filings on record, filed 2024-04-02 to 2026-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ADC Therapeutics SA (ADCT)Chief Executive Officer, Director71 leg · 29,731 sh · $133,1957
Atara Biotherapeutics, Inc. (ATRA)Director22

Form 4 filings — MALLIK AMEET

FiledFormIssuerReported transactionsSource
2026-07-024ADC Therapeutics SA (ADCT)Grant/award (A): 675,000 @ $0EDGAR
2026-02-184ADC Therapeutics SA (ADCT)Grant/award (A): 900,000 @ $3.99 · Tax withholding (F): 103,231 @ $3.99EDGAR
2025-12-094ADC Therapeutics SA (ADCT)Tax withholding (F): 233,146 @ $3.29EDGAR
2025-06-124Atara Biotherapeutics, Inc. (ATRA)Grant/award (A): 7,828 @ $0EDGAR
2025-05-084ADC Therapeutics SA (ADCT)Tax withholding (F): 26,758 @ $1.29EDGAR
2025-02-144ADC Therapeutics SA (ADCT)Grant/award (A): 650,000 @ $1.61EDGAR
2024-12-094ADC Therapeutics SA (ADCT)Tax withholding (F): 238,343 @ $3.13EDGAR
2024-05-094ADC Therapeutics SA (ADCT)Sale (S): 29,731 @ $4.48EDGAR
2024-04-024Atara Biotherapeutics, Inc. (ATRA)Grant/award (A): 150,000 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1861441 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →